Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Developing immunotherapy as legitimate therapy for patients with prostate cancer.

Small EJ, Fong L.

J Clin Oncol. 2010 Mar 1;28(7):1085-7. doi: 10.1200/JCO.2009.26.3483. Epub 2010 Jan 25. No abstract available.

PMID:
20100956
[PubMed - indexed for MEDLINE]
2.

[Vaccine therapy of prostate cancer].

Doehn C, Böhmer T, Sommerauer M, Kausch I, Jocham D.

Aktuelle Urol. 2005 Sep;36(5):407-16. Review. German.

PMID:
16163603
[PubMed - indexed for MEDLINE]
3.

Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.

Hwang C, Sanda MG.

Curr Opin Mol Ther. 1999 Aug;1(4):471-9. Review.

PMID:
11713762
[PubMed - indexed for MEDLINE]
4.

The role of poxviruses in tumor immunotherapy.

Kaufman HL.

Surgery. 2003 Nov;134(5):731-7. Review. No abstract available.

PMID:
14639347
[PubMed - indexed for MEDLINE]
5.

Current immunotherapeutic strategies in prostate cancer.

Grosso JF, Drake CG.

Surg Oncol Clin N Am. 2007 Oct;16(4):861-71, x. Review.

PMID:
18022549
[PubMed - indexed for MEDLINE]
6.

Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancer.

Arlen PM, Gulley JL, Tsang KY, Schlom J.

Expert Rev Vaccines. 2003 Aug;2(4):483-93. Review.

PMID:
14711334
[PubMed - indexed for MEDLINE]
7.

Immunotherapy for prostate cancer.

Fong L, Small EJ.

Semin Oncol. 2003 Oct;30(5):649-58. Review.

PMID:
14571412
[PubMed - indexed for MEDLINE]
8.

Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge).

Harzstark AL, Small EJ.

Expert Opin Biol Ther. 2007 Aug;7(8):1275-80. Review.

PMID:
17696825
[PubMed - indexed for MEDLINE]
9.

Optimizing prostate cancer treatment by combining local radiation therapy with systemic vaccination.

Kaufman HL, Divgi CR.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6757-62. Review. No abstract available.

PMID:
16203760
[PubMed - indexed for MEDLINE]
Free Article
10.

Advances in specific immunotherapy for prostate cancer.

Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M.

Eur Urol. 2008 Apr;53(4):694-708. Epub 2007 Nov 26. Review.

PMID:
18061335
[PubMed - indexed for MEDLINE]
11.

PSA-based vaccines for the treatment of prostate cancer.

Madan RA, Gulley JL, Arlen PM.

Expert Rev Vaccines. 2006 Apr;5(2):199-209. Review.

PMID:
16608420
[PubMed - indexed for MEDLINE]
12.

Immune-based therapies for prostate cancer.

McNeel DG, Malkovsky M.

Immunol Lett. 2005 Jan 15;96(1):3-9. Review.

PMID:
15585302
[PubMed - indexed for MEDLINE]
13.

Prostate-specific antigen vaccines for prostate cancer.

Hörig H, Lee CS, Kaufman HL.

Expert Opin Biol Ther. 2002 Apr;2(4):395-408. Review.

PMID:
11955277
[PubMed - indexed for MEDLINE]
14.

Prostate cancer immunotherapy.

McNeel DG.

Curr Opin Urol. 2007 May;17(3):175-81. Review.

PMID:
17414515
[PubMed - indexed for MEDLINE]
15.

CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.

Lubaroff DM, Karan D.

Adv Drug Deliv Rev. 2009 Mar 28;61(3):268-74. doi: 10.1016/j.addr.2008.12.005. Epub 2009 Jan 7. Review.

PMID:
19166887
[PubMed - indexed for MEDLINE]
16.

Prostate cancer vaccines: current status and future potential.

Doehn C, Böhmer T, Kausch I, Sommerauer M, Jocham D.

BioDrugs. 2008;22(2):71-84. Review.

PMID:
18345705
[PubMed - indexed for MEDLINE]
17.

Pitfalls or promise in prostate cancer immunotherapy-which is winning?

Slovin SF.

Cancer J. 2008 Jan-Feb;14(1):26-34. doi: 10.1097/PPO.0b013e318161bffa. Review.

PMID:
18303480
[PubMed - indexed for MEDLINE]
18.

Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects.

Minev BR, Guo F, Gueorguieva I, Kaiser HE.

In Vivo. 2002 Nov-Dec;16(6):405-15. Review.

PMID:
12494883
[PubMed - indexed for MEDLINE]
19.

Prostate-specific membrane antigen vaccines: naked DNA and protein approaches.

Slovin SF.

Clin Prostate Cancer. 2005 Sep;4(2):118-23. Review.

PMID:
16197613
[PubMed - indexed for MEDLINE]
20.

Immunotherapy for prostate cancer: what's the future?

Arlen PM, Dahut WL, Gulley JL.

Hematol Oncol Clin North Am. 2006 Aug;20(4):965-83, xi. Review.

PMID:
16861126
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk